The study of antitumor efficacy of bevacizumab antiangiogenic therapy using a mathematical model (Q890244): Difference between revisions
From MaRDI portal
Created a new Item |
Set OpenAlex properties. |
||
| (2 intermediate revisions by 2 users not shown) | |||
| Property / MaRDI profile type | |||
| Property / MaRDI profile type: MaRDI publication profile / rank | |||
Normal rank | |||
| Property / full work available at URL | |||
| Property / full work available at URL: https://doi.org/10.1515/rnam-2015-0026 / rank | |||
Normal rank | |||
| Property / OpenAlex ID | |||
| Property / OpenAlex ID: W2565884202 / rank | |||
Normal rank | |||
| links / mardi / name | links / mardi / name | ||
Latest revision as of 00:21, 20 March 2024
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The study of antitumor efficacy of bevacizumab antiangiogenic therapy using a mathematical model |
scientific article |
Statements
The study of antitumor efficacy of bevacizumab antiangiogenic therapy using a mathematical model (English)
0 references
10 November 2015
0 references
tumor modelling
0 references
antiangiogenic therapy
0 references
VEGF
0 references
bevacizumab
0 references
